SCHEMBL27907009

SCHEMBL27907009

COC(=O)c1ccc(C(=O)O)c(N)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
MAPK1 P28482 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GABRP O00591 2/20 0.43
GABRD O14764 2/20 0.43
GABRA1 P14867 2/20 0.43
GABRB1 P18505 2/20 0.43
GABRG2 P18507 2/20 0.43
GABRB3 P28472 2/20 0.43
GABRA5 P31644 2/20 0.43
GABRA3 P34903 2/20 0.43
GABRA2 P47869 2/20 0.43
GABRB2 P47870 2/20 0.43
GABRA4 P48169 2/20 0.43
GABRE P78334 2/20 0.43
GABRA6 Q16445 2/20 0.43
GABRG1 Q8N1C3 2/20 0.43
GABRG3 Q99928 2/20 0.43
GABRQ Q9UN88 2/20 0.43
ALDH1A1 P00352 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14956928 0.89 ALDH1A1 (0.47) KDM4EMAPK1ALDH1A1GAAHSD17B10
SCHEMBL27473142 0.82 GABRA1 (0.40) KDM4EGABRPGABRDGABRA1GABRB1
SCHEMBL14957462 0.81 NAPRT (0.48) KDM4EMAPK1L3MBTL1GABRPGABRD
SCHEMBL28577809 0.81 GABRP (0.53) KDM4EMAPK1L3MBTL1GABRPGABRD
SCHEMBL27788813 0.80 GABRP (0.47) KDM4EMAPK1L3MBTL1GABRPGABRD
SCHEMBL5554420 0.80 MAPK1 (0.46) KDM4EMAPK1ALDH1A1GAAHSD17B10
SCHEMBL14967079 0.79 ALDH1A1 (0.45) KDM4EMAPK1L3MBTL1ALDH1A1GAA
SCHEMBL1615816 0.79 MAPK1 (0.44) KDM4EMAPK1L3MBTL1ALDH1A1GAA
SCHEMBL31354558 0.79 LCK (0.46) MAPK1ALDH1A1GAAHSD17B10MAPT
SCHEMBL12462531 0.79 LCK (0.46) MAPK1ALDH1A1GAAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103119043-A Fused heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL 2013-05-22 CN disclosed